Genelux Corporation (GNLX) is a cutting-edge clinical-stage biopharmaceutical company headquartered in Westlake Village, California, dedicated to revolutionizing cancer treatment through its proprietary oncolytic viral immunotherapy platform. Focused on addressing aggressive solid tumors, Genelux is committed to developing innovative therapies that enhance the immune system's ability to combat cancer, thereby improving patient outcomes. With an expanding pipeline of promising treatments and a strong emphasis on addressing unmet medical needs in oncology, Genelux is well-positioned to become a key player in the evolving landscape of immunotherapy. Show more

Location: 2625 TOWNSGATE ROAD, WESTLAKE VILLAGE, CA, UNITED STATES, 91361, Westlake Village, CA, 91361, USA | Website: https://www.genelux.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

119M

52 Wk Range

$1.99 - $8.54

Previous Close

$2.74

Open

$2.70

Volume

148,460

Day Range

$2.61 - $2.76

Enterprise Value

104.2M

Cash

4.692M

Avg Qtr Burn

-6.575M

Insider Ownership

10.89%

Institutional Own.

26.76%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Olvi-Vec (Olvimulogene nanivacirepvec) + platinum-doublet + bevacizumab Details Cancer, Platinum-resistant ovarian cancer, Ovarian cancer	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Olvi-Vec (Olvimulogene nanivacirepvec) Details Cancer, Non-small cell lung carcinoma	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Olvi-Vec (Olvimulogene nanivacirepvec) Details Cancer, Small cell lung cancer	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.